Eupraxia Pharmaceuticals Statistics

Total Valuation

EPRX has a market cap or net worth of $156.21 million. The enterprise value is $159.08 million.

Market Cap	156.21M
Enterprise Value	159.08M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

EPRX has 35.85 million shares outstanding. The number of shares has increased by 37.52% in one year.

Current Share Class	35.85M
Shares Outstanding	35.85M
Shares Change (YoY)	+37.52%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	24.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.78
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.00, with a Debt / Equity ratio of 0.00.

Current Ratio	13.00
Quick Ratio	12.59
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-43.00

Financial Efficiency

Return on equity (ROE) is -116.77% and return on invested capital (ROIC) is -62.63%.

Return on Equity (ROE)	-116.77%
Return on Assets (ROA)	-52.06%
Return on Invested Capital (ROIC)	-62.63%
Return on Capital Employed (ROCE)	-101.48%
Revenue Per Employee	n/a
Profits Per Employee	-$826,308
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-402
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.67% in the last 52 weeks. The beta is 1.43, so EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	+66.67%
50-Day Moving Average	3.87
200-Day Moving Average	3.31
Relative Strength Index (RSI)	67.87
Average Volume (20 Days)	14,546

Short Selling Information

The latest short interest is 172,198, so 0.48% of the outstanding shares have been sold short.

Short Interest	172,198
Short Previous Month	139,261
Short % of Shares Out	0.48%
Short % of Float	0.69%
Short Ratio (days to cover)	10.50

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.43M
Pretax Income	-23.08M
Net Income	-27.27M
EBITDA	-27.32M
EBIT	-27.43M
Earnings Per Share (EPS)	-$0.76

Full Income Statement

Balance Sheet

The company has $27.45 million in cash and $52,774 in debt, giving a net cash position of $27.40 million or $0.76 per share.

Cash & Cash Equivalents	27.45M
Total Debt	52,774
Net Cash	27.40M
Net Cash Per Share	$0.76
Equity (Book Value)	27.03M
Book Value Per Share	-0.09
Working Capital	26.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.86 million and capital expenditures -$266,482, giving a free cash flow of -$30.13 million.

Operating Cash Flow	-29.86M
Capital Expenditures	-266,482
Free Cash Flow	-30.13M
FCF Per Share	-$0.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.52%
Shareholder Yield	-37.52%
Earnings Yield	-17.46%
FCF Yield	-19.29%

Analyst Forecast

The average price target for EPRX is $9.00, which is 106.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	106.90%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-23.05%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1